Cytologi versus HPV testing for deteksjon av celleforandringer i livmorhalsen.
Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
J Clin Microbiol 2012 Jun;50(6):1927-35. Epub 2012 apr 18
Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.
Gynecol Oncol 2011 Nov;123(2):257-62. Epub 2011 aug 12
HPV genotype distribution according to severity of cervical neoplasia.
Gynecol Oncol 2010 Jul;118(1):29-34. Epub 2010 apr 20
Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Expert Rev Mol Diagn 2008 Jul;8(4):405-15.
Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade
27th International Papillomavirus Conference and Clinical Workshop, 17-21 September 2011, Berlin, Germany
HPV mnRNA- testing etter konisering for å predikere tilbakevendende CIN2+
Årsmøte, Norsk gynokologisk forening, Ålesund, 8-10 September 2011
HPV genotype distribution and E6/E7 mRNA expression in Norwegian women with cervical neoplasia
NFOG 2008 Congress Reykjavik June 14-17 2008.
Testing for Human Papillomavirus and Cervical neoplasia
- desember 2012
- Christine M. Jonassen
- mars 2011
- Anne Eskild